(21 kb)
Foreign Direct Investment in Pharmaceuticals sector – clarification
RBI/2013-14/567
A.P. (DIR Series) Circular No.124
April 21, 2014
To
All Category – I Authorised Dealer Banks
Madam / Sir,
Foreign Direct Investment in  Pharmaceuticals sector – clarification
Attention  of Authorised Dealers Category – I (AD  Category - I) banks is invited to
A.P.  (DIR Series) Circular No.56 dated December 9, 2011
and the Foreign Exchange  Management (Transfer or Issue of Security by a Person Resident Outside India)  Regulations, 2000, notified vide
Notification  No. FEMA 20/2000-RB dated May 3, 2000
, as amended from time to time. In terms of Schedule 1 to the Notification  ibid, Foreign Direct Investment (FDI) up to 100 per cent is permitted under  automatic route for greenfield  investments and FDI up to 100 per cent is permitted under Government approval  route for brownfield investments (i.e. investments in existing companies) in  pharmaceuticals sector.
2. The extant FDI policy for pharmaceutical  sector has since been reviewed and it has now been decided with immediate  effect that  the existing policy would continue with the condition that ‘non-compete’ clause  would not be allowed except in special circumstances with the approval of the Foreign Investment Promotion Board (FIPB) of the Government of  India.
3. A copy of
Press Note No.1 (2014 Series)
dated January 8, 2014 issued in this regard by Department  of Industrial Policy and Promotion, Ministry of Commerce & Industry, Government  of India is enclosed.
4. AD Category  - I banks may bring the contents of the circular to the notice of their  customers/constituents concerned.
5. Reserve Bank has since amended the subject  Regulations accordingly through the Foreign Exchange Management (Transfer or  Issue of Security by a Person Resident outside India) (Amendment) Regulations,  2014 which have been notified vide
Notification  No. FEMA.296/2014-RB dated March 3, 2014
, vide G.S.R. No. 270(E) dated April  7, 2014.
6.  The directions contained in this circular have been issued under Sections 10(4)  and 11(1) of the Foreign Exchange Management Act, 1999 (42 of 1999) and are  without prejudice to permissions / approvals, if any, required under any other  law.
Yours faithfully,
(C.D.Srinivasan)
Chief  General Manager